Chung, Choon-Hee

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial

Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,829

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Pieber, T. R., Bode, B., Mertens, A., Cho, Y. M., Christiansen, E., Hertz, C. L., Wallenstein, S. O. R., Buse, J. B., Akın, S., Aladağ, N., et al. (2019) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 287

Basal‐prandial versus premixed insulin in patients with type 2 diabetes requiring insulin intensification after basal insulin optimization: A 24‐week randomized non‐inferiority trial: 接受基础胰岛素优化治疗之后需要胰岛素强化治疗的患者使用基础‐餐时胰岛素治疗与使用预混胰岛素治疗的对照试验:一项为期24周的随机非劣性试验

Jin, S., Kim, J. H., Min, K. W., Lee, J. H., Ahn, K. J., Park, J. H., Jang, H. C., Park, S. W., Lee, K. W., Won, K. C., et al. (2016) · Journal of Diabetes

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 23